Skip to main content

Valeo Pharmainc(VPH-T)
TSX

Today's Change
Real-Time Last Update

Valeo Pharma: Bottom 25 Performing Stocks Year-to-Date on TSX (VPH)

AI-generated - The Globe and Mail - Thu Dec 7, 2023

Valeo Pharma Inc is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.

SymbolNameTotal ReturnPeriod
ANRGAnaergia Inc-93.778802YTD
HZMHorizonte Minerals PLC-93.360996YTD
AUMNGolden Minerals Co-92.547945YTD
GBARMonarch Mining Corp-91.666667YTD
LPENLoop Energy Inc-91.428571YTD
MAVMAV Beauty Brands Inc-91.111111YTD
TMDTitan Medical Inc-90.555556YTD
OPTOptiva Inc-85.454545YTD
OREAOrea Mining Corp-84.210526YTD
AXISAxis Auto Finance Inc-83.333333YTD
NPKVerde AgriTech Ltd-78.787879YTD
SDESpartan Delta Corp-78.461538YTD
IVQInvesque Inc-78.455285YTD
SOT-UNSlate Office REIT-77.548611YTD
PEAPieridae Energy Ltd-76.4YTD
IVQ-UInvesque Inc-76.373626YTD
CUBCubicFarm Systems Corp-75YTD
EXNExcellon Resources Inc-75YTD
VPHValeo Pharma Inc-72.807018YTD
NCPNickel Creek Platinum Corp-72.727273YTD
APSAptose Biosciences Inc-71.538459YTD
VRTSVertiqal Studios-71.428571YTD
GENMGeneration Mining Ltd-71.153846YTD
BUBurcon NutraScience Corp-70.12987YTD
WEEDCanopy Growth Corp-70.063694YTD

All data provided as of December 06, 2023.

More about Valeo Pharma Inc

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Valeo Pharma Inc is listed under VPH on the Toronto Stock Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

More from The Globe